Login

Christoph Vilanek is the CEO of Freenet. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
C. Vann Woodward: America's Historian and His Influence|James Cobb,Professor,University of Georgia
00:10:00
Richardson Electronics, Ltd. (NASDAQ: RELL) CEO Edward Richardson sat down with Proactive Investors at the 11th Annual LD Micro Main Event.
00:10:00
Analyzing the European Credit Markets: Madelaine Jones on Bloomberg Markets Europe 2023
00:10:00
Onyx Gold's Exploration Strategy and Upcoming Drilling Projects
00:10:00
Air New Zealand CEO Greg Foran Discusses Government Bailout, Repatriation, and Staffing Challenges | Greg Foran, CEO, Air New Zealand .
00:10:00
CEO Reflects on Company's Resilience and Future Outlook | Daniel Pimentel Slaviero, CEO, Companhia Paranaense de Energia.
00:10:00
8VC partners with elite founders to build transformational technologies|Alex Kolicich,Founding Partner,8VC
00:10:00
Oli Barrett interviews Nick Bolton, CEO of Oxford Metrics, about the crucial role of maintaining balance in business for overall success.|Imogen was appointed CEO of Oxford Metrics
00:10:00
Marcelo Fabiano in Cielo Pelo Brasil | Estanislau Bassols, CEO, CIELO SA Instituicao de PagamentoCIEL3:SAO
00:10:00
The president of The Musuneggi Financial Group leads a financial advisory firm affiliated with Grove Point Investments, LLC and Grove Point Advisors, LLC.
00:10:00
The Hidden Costs of Renewable Energy Credits: A Warning for Corporates | William Gore-Randall - Research Analyst at Lazard Asset Management
00:10:00
Chiome Bioscience leverages cutting-edge antibody technology for drug discovery and development| Shigeru Kobayashi,CEO, Chiome Bioscience Inc.

© 2017 - Neuhu+